NCT02526472

Brief Summary

One thousand, six hundred forty-eight IVF patients undergoing ET with fresh embryos, randomized to receive mTVET (n=828) or UGET (n=820). The transfer in uteri of 1-2 embryos on day 2-3 of culture was performed using a soft catheter either under trans-abdominal US guidance (UGET group) or after measurement of uterine cavity by transvaginal US and calculation of the discharge site (mTVET). Mai outcome measures was the clinical pregnancy rate (CPR), secondary outcomes were the implantation rate (IR), and the patient's discomfort during ET procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,648

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 13, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 18, 2015

Completed
Last Updated

August 18, 2015

Status Verified

August 1, 2015

Enrollment Period

2.9 years

First QC Date

August 13, 2015

Last Update Submit

August 16, 2015

Conditions

Keywords

embryo transfer, in vitro fertilization

Outcome Measures

Primary Outcomes (2)

  • clinical pregnancy rate per embryo transfer (CPR/ET)

    3 years

  • implantation rate

    3 weeks (until the pregnancy test is performed)

Secondary Outcomes (1)

  • proportion of patients feeling moderate-to-severe discomfort during ET

    3 years

Study Arms (2)

transabdominal US guidance (UGET)

EXPERIMENTAL

ET under transabdominal US guidance (UGET)

Procedure: ET under transabdominal US guidance (UGET)

TV-US ET guidance (mTVET)

EXPERIMENTAL

ET after transvaginal US uterine measurement (mTVET)

Procedure: ET after transvaginal US uterine measurement (mTVET)

Interventions

When UGET was used, a second physician performed trans-abdominal US, and the embryos were discharged when the tip of the catheter was visualized approximately at 1,5 cm from the fundal endometrial surface

transabdominal US guidance (UGET)

When mTVET was scheduled, the physician performed a transvaginal US scan just before ET, measured the length of the cervix and of the uterine cavity, and calculated the distance between the internal uterine os and the fundal endometrial surface. Then, ET was performed inserting the inner cannula in order to discharge embryos at a point obtained subtracting 1.5 cm from the total length of the cavity.

TV-US ET guidance (mTVET)

Eligibility Criteria

Age18 Years - 43 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients undergoing autologous IVF
  • ending IVF cycle with the transfer of fresh embryos
  • treated at the investigators'r IVF Unit between Jan 2012 to Dec 2014

You may not qualify if:

  • patients undergoing donor IVF
  • ending IVF cycle without embryo transfer
  • transferring frozen-thawed embryos
  • treated elsewhere

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physiopathology of Reproduction and IVF Unit, S. Anna Hospital

Torino, 10126, Italy

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Alberto Revelli, Prof.

    Dept. Surgical Sciences, Sant'Anna Hospital, University of Torino, Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 13, 2015

First Posted

August 18, 2015

Study Start

January 1, 2012

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

August 18, 2015

Record last verified: 2015-08

Locations